Pharmacology, Toxicology and Pharmaceutical Science
Paclitaxel
100%
Pharmacokinetics
74%
Sorafenib
69%
Chemotherapy
51%
Esophagus Cancer
41%
Liver Cell Carcinoma
39%
Angiogenesis Inhibitor
37%
Chemoradiation Therapy
26%
Cimetidine
25%
Organic Cation Transporter 2
25%
Cyclooxygenase 2
25%
Taxane
25%
Docetaxel
25%
Vasculotropin Inhibitor
23%
Overall Survival
21%
Side Effect
20%
Capecitabine
18%
Anticancer Drug
18%
Carboplatin
18%
Allergic Reaction
17%
Nephrotoxicity
16%
Cyclooxygenase 1
15%
Acetylsalicylic Acid
15%
Neoplasm
15%
Thyroiditis
14%
Kidney Injury
14%
Cohort Study
14%
Diseases
14%
Sunitinib
13%
Clemastine
13%
Protein Tyrosine Kinase Inhibitor
12%
Pharmacogenetics
12%
Cisplatin
12%
Pharmacodynamics
12%
Liver Cancer
12%
Proton Pump Inhibitor
12%
Irinotecan
12%
Infusion Pump
12%
Adenocarcinoma
12%
Floxuridine
12%
Esomeprazole
12%
Colorectal Liver Metastasis
12%
Probenecid
12%
Thyroid Cancer
12%
Therapeutic Drug Monitoring
12%
Histamine H2 Receptor Antagonist
12%
Ranitidine
12%
Trifluridine
12%
Metformin
12%
Thyroid Hormone
12%
Medicine and Dentistry
Paclitaxel
43%
Overall Survival
30%
Esophageal Cancer
29%
Chemoradiotherapy
29%
Hepatic Arterial Infusion
25%
Colorectal Liver Metastasis
25%
Premedication
25%
Vasculotropin Inhibitor
23%
Diseases
18%
Carboplatin
18%
Allergic Response
17%
Progression Free Survival
16%
Retrospective Cohort Study
16%
Neoplasm
15%
Clemastine
13%
Ranitidine
12%
Floxuridine
12%
Cardiovascular Toxicity
12%
Adenocarcinoma
12%
Esophagus
12%
Immune Checkpoint Inhibitor
12%
Angiogenesis Inhibitor
12%
Symptomatic Treatment
12%
Cardiovascular Risk
12%
H2 Antagonist
12%
Sodium Intake
12%
Sodium Restriction
12%
H1 Antagonist
12%
Histamine H1 Receptor
12%
Cetirizine
12%
Combination Therapy
6%